Global Assisted Reproductive Technology ART Market, By Procedure (Fresh Donor, Fresh Nondonor, Frozen Donor, Frozen Nondonor, and Embryo/Egg Banking), Technology (In-vitro Fertilization (IVF), Artificial Insemination - Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), Surrogacy, Ovulation Induction, and Others), Product Type (Women Younger Than Age 35 and Women Older Than Age 35), End Use (Hospitals, Fertility Clinics, and Others) – Industry Trends and Forecast to 2031.
Assisted Reproductive Technology ART Market Analysis and Size
The Assisted Reproductive Technology (ART) market is experiencing significant growth, driven by factors such as increasing infertility rates, advancements in technology, and growing awareness and acceptance of ART procedures. The market is characterized by a rise in the number of couples seeking infertility treatments, along with a growing trend towards delayed parenthood. In addition, factors such as the increasing prevalence of conditions such as polycystic ovary syndrome (PCOS) and endometriosis, which can contribute to infertility, are driving market growth. Furthermore, the availability of various ART procedures, such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and surrogacy, is expanding the options for couples seeking to conceive.
The global assisted reproductive technology ART market size was valued at USD 28.49 billion in 2023 and is projected to reach USD 54.32 billion by 2031, with a CAGR of 8.4% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Procedure (Fresh Donor, Fresh Nondonor, Frozen Donor, Frozen Nondonor, and Embryo/Egg Banking), Technology (In-vitro Fertilization (IVF), Artificial Insemination - Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), Surrogacy, Ovulation Induction, and Others), Product Type (Women Younger Than Age 35 and Women Older Than Age 35), End Use (Hospitals, Fertility Clinics, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America
|
|
Market Players Covered
|
California Cryobank (U.S.), Bloom Fertility Centre (India), Anecova (Switzerland), CooperSurgical (U.S.), Merck KGaA (Germany), Ferring B.V. (Switzerland), FUJIFILM Irvine Scientific (U.S.), Genea Limited (Australia), Nidacon International AB (Sweden), Celmatix Inc. (U.S.), Esco Micro Pte Ltd. (Singapore), INVO Bioscience (U.S.), Laboratoire CCD (France), Nikon Instruments Inc. (U.S.), and ICU Medical, Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Assisted Reproductive Technology (ART) refers to a range of medical procedures used to treat infertility. ART involves the manipulation of eggs, sperm, or embryos to help achieve pregnancy. Common ART procedures include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and gamete intrafallopian transfer (GIFT). Assisted reproductive technologies (ARTs) are usually used to treat infertility when other methods of achieving pregnancy, such as medication or surgery, have not been successful.
Assisted Reproductive Technology ART Market Dynamics
Drivers
- Increasing Infertility Rates
The prevalence of infertility is on the rise globally, fueled by various factors such as lifestyle changes, environmental factors, and age-related fertility issues. Modern lifestyles characterized by stress, unhealthy diet, and sedentary habits have contributed to hormonal imbalances and reproductive health issues, leading to an increase in infertility cases. Environmental factors such as exposure to pollutants and toxins can also negatively impact fertility. In addition, age-related fertility issues become more prevalent, with more couples choosing to start families later in life. These factors combined have led to a growing demand for ART procedures, driving market growth.
- Delayed Parenthood
Delayed parenthood has become increasingly common, driven by factors such as pursuing higher education, establishing careers, and financial stability. Many individuals and couples choose to delay starting a family until later in life, often in their 30s or even 40s. Although delaying parenthood offers benefits such as emotional maturity and financial security, it also presents challenges related to fertility. As individuals age, the quality and quantity of their eggs and sperm decrease, making conception more challenging. This has contributed to a growing demand for ART procedures among older individuals, as they seek assistance in overcoming age-related fertility issues and realizing their goal of starting a family, driving the market growth.
Opportunities
- Growing Awareness and Acceptance
There has been a significant increase in awareness about infertility treatments, with more individuals and couples seeking solutions to overcome fertility challenges. This growing awareness has been accompanied by a shift in societal attitudes towards ART, with more acceptance and understanding of these treatments as viable options for achieving pregnancy. As a result, there has been a notable increase in the number of couples seeking ART procedures. In addition, the recognition of male infertility as a significant factor in couples' inability to conceive has further fueled research and development efforts toward innovative treatments for male factor infertility, expanding the market opportunities.
- Technological Advancements in ART
There are continuous advancements in infertility art-assisted reproductive technology, leading to improved treatment outcomes and expanded options for patients. Technologies such as improved embryo culture techniques, genetic testing, and embryo selection methods have significantly enhanced the success rates of ART procedures. These advancements in embryo culture techniques have enhanced the monitoring and selection of embryos with the highest likelihood of successful implantation, thereby improving the overall success rates of IVF procedures. Similarly, genetic testing has enabled the screening of embryos for genetic abnormalities, reducing the risk of miscarriage and improving the chances of a successful pregnancy. These technological advancements have not only improved the effectiveness of ART procedures but have also expanded the treatment options available to patients, driving market growth.
Restraints/Challenges
- High Cost of ART Procedures
The expenses involved in ART can quickly add up, making it unaffordable for some individuals and couples. Factors contributing to the high cost of ART include the need for specialized medical equipment, laboratory procedures, and highly trained personnel. In addition, the cost of medications used in ART can be substantial, especially for hormone treatments required to stimulate ovulation. The financial burden of ART can be further exacerbated by the fact that success is not guaranteed, and multiple treatment cycles may be needed before achieving a successful pregnancy, leading to additional costs. As a result, the high cost of ART procedures remains a major challenge for many individuals and couples seeking infertility treatment.
- Health Risks in ART procedures
ART procedures can carry health risks for both the mother and the child, which need to be carefully considered before undergoing treatment. One of the primary risks associated with ART is the increased likelihood of multiple pregnancies, which can result in complications such as premature birth, low birth weight, and other health issues for both the mother and the babies. Women who undergo ART procedures face the risk of developing ovarian hyperstimulation syndrome (OHSS), which is characterized by enlarged and painful ovaries. While OHSS is usually mild, severe cases can lead to complications such as fluid buildup in the abdomen and chest, blood clots, and kidney failure. While assisted reproductive technology is an infertility treatment, the potential health risks associated with these procedures can be a challenge for market.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the assisted reproductive technology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In July 2021, Hamilton Throne Ltd., a worldwide leader in ART research, completed the acquisition of IVFTECH ApS (IVFtech) and its affiliated company, K4 Technology ApS. IVFtech specializes in supplying laminar flow workstations and high-capacity incubators for ART, leveraging the expertise of its affiliated firm, K4. The transaction was valued at USD 8 million
- In September 2020, Assisted Reproductive Technology ART bill was introduced in Lok Sabha. the Bill aims to regulate Assisted Reproductive Technology (ART) services in India. ART encompasses all techniques that aim to achieve pregnancy by manipulating sperm or oocytes outside the body and transferring the gamete or embryo into a woman's reproductive system. Instances of ART services include gamete donation, in-vitro fertilisation (fertilising an egg in a lab), and gestational surrogacy (where the child is not biologically related to the surrogate mother). ART services will be provided through ART clinics, which offer related treatments and procedures, and ART banks, which store and supply gametes
Assisted Reproductive Technology ART Market Scope
The market is segmented on the basis of procedure, technology, product type, and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Procedure
- Fresh Donor
- Fresh Nondonor
- Frozen Donor
- Frozen Nondonor
- Embryo/Egg Banking
Technology
- In-vitro Fertilization (IVF)
- IVF with Intracytoplasmic Sperm Injection (ICSI)
- IVF without ICSI
- Artificial Insemination - Intrauterine Insemination (AI-IUI)
- Frozen Embryo Replacement (FER)
- Surrogacy
- Ovulation Induction
- Others
Product Type
- Women Younger Than Age 35
- Women Older Than Age 35
End Use
- Hospitals
- Fertility Clinics
- Others
Assisted Reproductive Technology ART Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, procedure, technology, product type, and end-use as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
North America is expected to dominate the market due to a combination of rising infertility rates and a heightened awareness of available fertility treatments. The region's well-established healthcare infrastructure, coupled with high disposable income, enables greater access to and adoption of ART procedures. In addition, the presence of leading ART clinics and research facilities further helps the market growth in the region.
Asia-Pacific is expected to witness significant growth during the forecast period due to several factors, including the increasing trend of late family planning adoption, where couples are choosing to have children at a later age, leading to a higher demand for ART services. Moreover, the relatively lower costs of ART treatments in the Asia-Pacific region compared to other parts of the world make these services more accessible to a broader population. The region's improving healthcare infrastructure and advancements in ART technologies also contribute to its growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The assisted reproductive technology ART market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for assisted reproductive technology ART market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the assisted reproductive technology ART market. The data is available for historic period 2016-2021.
Competitive Landscape and Assisted Reproductive Technology ART Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the market are:
- California Cryobank (U.S.)
- Bloom Fertility Centre (India)
- Anecova (Switzerland)
- CooperSurgical (U.S.)
- Merck KGaA (Germany)
- Ferring B.V. (Switzerland)
- FUJIFILM Irvine Scientific (U.S.)
- Genea Limited (Australia)
- Nidacon International AB (Sweden)
- Celmatix Inc. (U.S.)
- Esco Micro Pte Ltd. (Singapore)
- INVO Bioscience (U.S.)
- Laboratoire CCD (France)
- Nikon Instruments Inc. (U.S.)
- ICU Medical, Inc. (U.S.)
SKU-